What is the management approach for a patient on anticoagulants (blood thinners) with elevated blood pressure (hypertension) and symptoms of giddiness and blurred vision after a recent head injury from a fall?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Head Injury in Anticoagulated Patient with Neurological Symptoms

Obtain an immediate non-contrast head CT scan and hold the blood thinner until intracranial hemorrhage is excluded. 1, 2

Immediate Actions in the Emergency Department

Neuroimaging

  • Perform urgent non-contrast head CT regardless of symptom severity or mechanism of injury 1, 2
  • The threshold for imaging is very low because anticoagulated patients have 3.9% risk of significant intracranial injury versus 1.5% in non-anticoagulated patients 1, 2
  • Giddiness and blurred vision after head trauma represent concerning neurological symptoms that mandate immediate imaging 1

Blood Pressure Management

  • In patients with acute intracerebral hemorrhage and systolic BP ≥220 mmHg, carefully lower BP with intravenous therapy to <180 mmHg 1
  • For systolic BP <220 mmHg, immediate aggressive BP lowering is not recommended 1
  • Target systolic BP of 140 mmHg is recommended within 6 hours of symptom onset if hemorrhage is confirmed, strictly avoiding SBP <110 mmHg 1

If Initial CT Shows Intracranial Hemorrhage

Anticoagulation Reversal

  • Immediately discontinue the blood thinner and reverse anticoagulation 1, 2
  • For warfarin with INR ≥2.0: administer 4-factor prothrombin complex concentrate (4F-PCC) plus 5mg intravenous vitamin K 1, 2
  • For factor Xa inhibitors (apixaban, rivaroxaban): use andexanet alfa if available; if unavailable, use 4F-PCC 1, 2
  • For dabigatran: administer idarucizumab 1
  • Obtain immediate neurosurgical consultation 2

Follow-up Imaging

  • Repeat head CT within 24 hours because anticoagulated patients have 3-fold increased risk of hemorrhage expansion (26% versus 9%) 2, 3
  • Most hemorrhage expansion occurs within the first 6 hours 3

If Initial CT is Negative

Observation Decision

  • For neurologically intact patients with negative initial CT, routine repeat imaging or admission is not necessary 1, 2, 4
  • Brief observation (4-6 hours) may be considered for high-risk features including: 2, 4
    • Age >80 years
    • History of loss of consciousness or amnesia
    • Glasgow Coma Scale <15
    • Concomitant use of multiple anticoagulant/antiplatelet agents

Risk of Delayed Hemorrhage

  • The risk of delayed intracranial hemorrhage after negative initial CT is low (0.6-6%) 1, 4
  • Delayed hemorrhage rarely requires neurosurgical intervention 1, 4
  • Patients on NOACs have only 1.5% delayed ICH rate with none requiring surgery 4

Anticoagulation Management

  • Continue the blood thinner if initial CT is negative and patient is neurologically intact 2, 4
  • Consider the indication for anticoagulation, as thromboembolic risk may outweigh the small risk of delayed hemorrhage 2, 4
  • One study showed only 1.1% suffered thromboembolic events when anticoagulation was held, but 41.2% had re-hemorrhage if anticoagulation was restarted with residual subdural hematoma 5

Discharge Instructions and Follow-up

Patient Education

  • Provide clear written instructions about signs of delayed hemorrhage: severe headache, confusion, vomiting, weakness, seizures 2
  • Instruct patient to return immediately or call 911 if these symptoms develop 2

Outpatient Management

  • Arrange fall risk assessment 2
  • Reassess anticoagulation risk/benefit ratio 2
  • Blood pressure should be controlled with antihypertensive medications if elevated BP persists after acute period 1

Common Pitfalls to Avoid

  • Failing to obtain initial CT imaging after any head trauma in anticoagulated patients, even with minor mechanisms like ground-level falls 1, 2
  • Unnecessarily admitting patients with negative initial CT for repeat imaging, which increases costs without improving outcomes 1, 2
  • Discontinuing anticoagulation without considering the indication and thromboembolic risk 2, 4
  • Delaying repeat imaging when neurological deterioration occurs 3
  • Aggressively lowering BP <110 mmHg, which can worsen outcomes 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Head Trauma in Anticoagulated Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Imaging Guidelines for Patients on Apixaban Anticoagulation with Head Trauma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Delayed Hemorrhage After Blunt Head Trauma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute Traumatic Subdural Hematoma and Anticoagulation Risk.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.